Pelthos Therapeutics, Inc. (PTHS)
22.85
+0.20
(+0.88%)
USD |
NYAM |
Sep 21, 16:00
22.85
0.00 (0.00%)
After-Hours: 20:00
Pelthos Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 4.819 |
| June 26, 2026 | 5.078 |
| June 25, 2026 | 5.109 |
| June 24, 2026 | 5.022 |
| June 23, 2026 | 5.16 |
| June 22, 2026 | 5.122 |
| June 18, 2026 | 5.072 |
| June 17, 2026 | 4.724 |
| June 16, 2026 | 4.901 |
| June 15, 2026 | 4.635 |
| June 12, 2026 | 4.810 |
| June 11, 2026 | 5.024 |
| June 10, 2026 | 4.796 |
| June 09, 2026 | 4.705 |
| June 08, 2026 | 4.600 |
| June 05, 2026 | 4.469 |
| June 04, 2026 | 4.523 |
| June 03, 2026 | 4.527 |
| June 02, 2026 | 4.548 |
| June 01, 2026 | 4.583 |
| May 29, 2026 | 4.63 |
| May 28, 2026 | 4.513 |
| May 27, 2026 | 4.716 |
| May 26, 2026 | 4.752 |
| May 22, 2026 | 4.663 |
| Date | Value |
|---|---|
| May 21, 2026 | 4.740 |
| May 20, 2026 | 4.742 |
| May 19, 2026 | 4.723 |
| May 18, 2026 | 4.574 |
| May 15, 2026 | 4.674 |
| May 14, 2026 | 4.843 |
| May 13, 2026 | 4.550 |
| May 12, 2026 | 4.765 |
| May 11, 2026 | 4.696 |
| May 08, 2026 | 4.459 |
| May 07, 2026 | 4.378 |
| May 06, 2026 | 4.373 |
| May 05, 2026 | 4.452 |
| May 04, 2026 | 4.341 |
| May 01, 2026 | 4.373 |
| April 30, 2026 | 4.373 |
| April 29, 2026 | 4.389 |
| April 28, 2026 | 4.368 |
| April 27, 2026 | 4.333 |
| April 24, 2026 | 4.034 |
| April 23, 2026 | 4.058 |
| April 22, 2026 | 4.023 |
| April 21, 2026 | 4.023 |
| April 20, 2026 | 4.014 |
| April 17, 2026 | 4.026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Travere Therapeutics, Inc. | 241.29 |
| ACADIA Pharmaceuticals, Inc. | 3.477 |
| Alnylam Pharmaceuticals, Inc. | 24.12 |
| Anika Therapeutics, Inc. | 2.020 |
| Savara, Inc. | 7.799 |
Price to Book Value Related Metrics
| PS Ratio | 1.724 |
| PEG Ratio | -0.0046 |
| Price | 22.85 |
| Earnings Yield | -115.4% |
| Market Cap | 84.97M |
| PEGY Ratio | -0.0046 |